We are proud to announce that a joint venture lead by Heliant has been chosen to develop the National Cancer Register of the Republic of Serbia.
The register will support the Institute of Public Health of Serbia “Dr Milan Jovanovic Batut”, in terms of monitoring, reporting, planning, and strategic decision making.
Serbia is in a group of countries with a medium risk of malignancy and with a high risk of dying from it. Our physicians, epidemiologists, scientists, and many other experts are making great efforts to reduce these risks.
Advanced software solution for automatic data collection about patients with cancer will make this much easier. Aggregated data will be available for control and epidemiological researches, while at the same time it will be made available to the public.